Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 3, 2007 - Issue 6
Submit an article Journal homepage
323
Views
44
CrossRef citations to date
0
Altmetric
Review

Drug resistance in cancer – searching for mechanisms, markers and therapeutic agents

Robert O'Connor Dublin City University, National Institute for Cellular Biotechnology (NICB), Dublin 9, Ireland +353 1 700 5700; +353 1 700 5484; [email protected]
, PhD,
Martin Clynes Dublin City University, National Institute for Cellular Biotechnology (NICB), Dublin 9, Ireland +353 1 700 5700; +353 1 700 5484; [email protected]
, PhD,
Paul Dowling Dublin City University, National Institute for Cellular Biotechnology (NICB), Dublin 9, Ireland +353 1 700 5700; +353 1 700 5484; [email protected]
, PhD,
Norma O'Donovan Dublin City University, National Institute for Cellular Biotechnology (NICB), Dublin 9, Ireland +353 1 700 5700; +353 1 700 5484; [email protected]
, PhD &
Lorraine O'Driscoll Dublin City University, National Institute for Cellular Biotechnology (NICB), Dublin 9, Ireland +353 1 700 5700; +353 1 700 5484; [email protected]
, PhD
Pages 805-817 | Published online: 21 Nov 2007

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Rajeev Rajendra, Robin L Jones & Seth M Pollack. (2013) Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib. OncoTargets and Therapy 6, pages 217-222.
Read now
Brendan Corkery, Norma O’Donovan & John Crown. (2008) Targeted treatment of advanced and metastaticbreast cancer with lapatinib. OncoTargets and Therapy 1, pages 21-34.
Read now

Articles from other publishers (42)

Kaiyu Shen, Shuaiyi Ke, Binyu Chen & Wencang Gao. (2023) Integrated analysis of single-cell and bulk RNA-sequencing reveals the poor prognostic value of ABCA1 in gastric adenocarcinoma. Discover Oncology 14:1.
Crossref
Wei Sun, Erhu Zhao & Hongjuan Cui. (2022) Target enzymes in serine‐glycine‐one‐carbon metabolic pathway for cancer therapy. International Journal of Cancer 152:12, pages 2446-2463.
Crossref
Frontiers Production Office. (2023) Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma. Frontiers in Pharmacology 14.
Crossref
Valentina Laghezza Masci, Davide Stefanoni, Angelo D’Alessandro, Marta Zambelli, Lorenzo Modesti, Daniele Pollini, Elisa Ovidi & Antonio Tiezzi. (2023) Induction of Drug-Resistance and Production of a Culture Medium Able to Induce Drug-Resistance in Vinblastine Untreated Murine Myeloma Cells. Molecules 28:5, pages 2051.
Crossref
Lei Jiang, Luan Li, Yongzhuang Liu, Meixiao Zhan, Ligong Lu, Shengtao Yuan & Yanyan Liu. (2023) Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma. Frontiers in Pharmacology 14.
Crossref
Sunique van Loggenberg, Clarissa Willers, Frank van der Kooy, Chrisna Gouws, Josias Hendrik Hamman & Johan Dewald Steyn. (2022) Evaluating in vitro cytotoxic effects of Artemisia afra and Artemisia annua infusions against selected lung cancer cell lines. South African Journal of Botany 150, pages 404-411.
Crossref
Ramanpreet Kaur, Shruthi Kanthaje, Sunil Taneja, Radha K. Dhiman & Anuradha Chakraborti. (2022) miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line. Genes 13:8, pages 1375.
Crossref
Beatriz Bueschbell, Ana Beatriz Caniceiro, Pedro M.S. Suzano, Miguel Machuqueiro, Nícia Rosário-Ferreira & Irina S. Moreira. (2022) Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer. Drug Resistance Updates 60, pages 100811.
Crossref
Xin Guan, Yi Wu, Shuqin Zhang, Zhiyi Liu, Qingjie Fan, Shuai Fang, Sennan Qiao, Fei Sun & Chongyang Liang. (2021) Activation of FcRn Mediates a Primary Resistance Response to Sorafenib in Hepatocellular Carcinoma by Single-Cell RNA Sequencing. Frontiers in Pharmacology 12.
Crossref
Vibha Singh & Christophe Lamaze. (2020) Membrane tension buffering by caveolae: a role in cancer?. Cancer and Metastasis Reviews 39:2, pages 505-517.
Crossref
Mohammed A.I. Elbastawesy, Mohamed Ramadan, Yaseen A.M.M. El-Shaier, Ashraf A. Aly & Gamal El-Din A. Abuo-Rahma. (2020) Arylidenes of Quinolin-2-one scaffold as Erlotinib analogues with activities against leukemia through inhibition of EGFR TK/ STAT-3 pathways. Bioorganic Chemistry 96, pages 103628.
Crossref
A. Tolios, J. De Las Rivas, E. Hovig, P. Trouillas, A. Scorilas & T. Mohr. (2020) Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions. Drug Resistance Updates 48, pages 100662.
Crossref
Jeong-Ju Yoo, Su Yu, Juri Na, Kyungmin Kim, Young Cho, Yun Lee, Eun Cho, Jeong-Hoon Lee, Yoon Kim, Hyewon Youn & Jung-Hwan Yoon. (2019) Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma. International Journal of Molecular Sciences 20:6, pages 1292.
Crossref
Julia Ketteler & Diana Klein. (2018) Caveolin-1, cancer and therapy resistance. International Journal of Cancer 143:9, pages 2092-2104.
Crossref
Jimin Dai, Qichao Huang, Kunwei Niu, Bo Wang, Yijie Li, Chen Dai, Zhinan Chen, Kaishan Tao & Jingyao Dai. (2018) Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma. Cancer Medicine 7:11, pages 5691-5703.
Crossref
Jie Mao, Hongbao Yang, Tingting Cui, Pan Pan, Nadia Kabir, Duo Chen, Jinyan Ma, Xingyi Chen, Yijun Chen & Yong Yang. (2018) Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT. European Journal of Pharmacology 832, pages 39-49.
Crossref
Wenbo Zhan, Moath Alamer & Xiao Yun Xu. (2018) Computational modelling of drug delivery to solid tumour: Understanding the interplay between chemotherapeutics and biological system for optimised delivery systems. Advanced Drug Delivery Reviews 132, pages 81-103.
Crossref
Wei-Wei Tong, Guang-Hui Tong & Yong Liu. (2018) Cancer stem cells and hypoxia-inducible factors (Review). International Journal of Oncology.
Crossref
Néstor Prieto-Domínguez, Carolina Méndez-Blanco, Sara Carbajo-Pescador, Flavia Fondevila, Andrés García-Palomo, Javier González-Gallego & José L. Mauriz. (2017) Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy. Oncotarget 8:53, pages 91402-91414.
Crossref
Yan-jing Zhu, Bo Zheng, Hong-yang Wang & Lei Chen. (2017) New knowledge of the mechanisms of sorafenib resistance in liver cancer. Acta Pharmacologica Sinica 38:5, pages 614-622.
Crossref
Qian Zhang, Yunjiang Feng & Derek Kennedy. (2016) Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?. Cellular and Molecular Life Sciences 74:5, pages 777-801.
Crossref
Bibek Aryal, Christophe Laurent & Markus Geisler. (2016) Correction: Learning from each other: ABC transporter regulation by protein phosphorylation in plant and mammalian systems. Biochemical Society Transactions 44:2, pages 663-673.
Crossref
Naglaa F. Khedr & Rania M. Khalil. (2015) Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin. Tumor Biology 36:12, pages 9267-9275.
Crossref
Bibek Aryal, Christophe Laurent & Markus Geisler. (2015) Learning from each other: ABC transporter regulation by protein phosphorylation in plant and mammalian systems. Biochemical Society Transactions 43:5, pages 966-974.
Crossref
Cong Liu, J. Krishnan & Xiao Yun Xu. (2015) Intrinsic and induced drug resistance mechanisms: in silico investigations at the cellular and tissue scales. Integrative Biology 7:9, pages 1044-1060.
Crossref
Hong Sun. (2014) Role of anti-angiogenesis therapy in the management of hepatocellular carcinoma: The jury is still out. World Journal of Hepatology 6:12, pages 830.
Crossref
Sandro De Falco. (2014) Antiangiogenesis therapy: an update after the first decade. The Korean Journal of Internal Medicine 29:1, pages 1.
Crossref
Magdalena Buczek, Bernard Escudier, Ewa Bartnik, Cezary Szczylik & Anna Czarnecka. (2014) Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: From the patient's bed to molecular mechanisms. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1845:1, pages 31-41.
Crossref
Lee Rivera, Melissa Pandika & Gabriele Bergers. 2014. Tumor Microenvironment and Cellular Stress. Tumor Microenvironment and Cellular Stress 83 99 .
Su Jong Yu & Jung-Hwan Yoon. (2013) Molecular targeted therapy with transarterial chemoembolization. Gastrointestinal Intervention 2:2, pages 78-81.
Crossref
Bo Zhai. (2013) Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma. World Journal of Hepatology 5:7, pages 345.
Crossref
Cong Liu, J. Krishnan & Xiao Yun Xu. (2013) Investigating the effects of ABC transporter-based acquired drug resistance mechanisms at the cellular and tissue scale. Integrative Biology 5:3, pages 555.
Crossref
Inken Wierstra. 2013. 191 419 .
John W. Pepper. (2012) Drugs that target pathogen public goods are robust against evolved drug resistance. Evolutionary Applications 5:7, pages 757-761.
Crossref
Lionel Faivre, Charline Gomo, Olivier Mir, Fabrice Taieb, Audrey Schoemann-Thomas, Stanislas Ropert, Michel Vidal, Daniel Dusser, Alain Dauphin, Francois Goldwasser & Benoit Blanchet. (2011) A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasma. Journal of Chromatography B 879:23, pages 2345-2350.
Crossref
Feng Huang, Shaojing Li, Xinhua Lu, Ailin Liu, Guanhua Du & Ganggang Shi. (2011) Two glutathione S-transferase inhibitors from Radix Angelicae sinensis. Phytotherapy Research 25:2, pages 284-289.
Crossref
Mathias Viard, Himanshu Garg, Robert Blumenthal & Yossef Raviv. (2009) Photo-activation of the hydrophobic probe iodonaphthylazide in cells alters membrane protein function leading to cell death. BMC Cell Biology 10:1.
Crossref
Sandra Roche, Gillian McMahon, Martin Clynes & Robert O’Connor. (2009) Development of a high-performance liquid chromatographic–mass spectrometric method for the determination of cellular levels of the tyrosine kinase inhibitors lapatinib and dasatinib. Journal of Chromatography B 877:31, pages 3982-3990.
Crossref
John W. Pepper, C. Scott Findlay, Rees Kassen, Sabrina L. Spencer & Carlo C. Maley. (2009) SYNTHESIS: Cancer research meets evolutionary biology. Evolutionary Applications 2:1, pages 62-70.
Crossref
John W. Pepper. (2008) DEFEATING PATHOGEN DRUG RESISTANCE: GUIDANCE FROM EVOLUTIONARY THEORY. Evolution 62:12, pages 3185-3191.
Crossref
Gabriele Bergers & Douglas Hanahan. (2008) Modes of resistance to anti-angiogenic therapy. Nature Reviews Cancer 8:8, pages 592-603.
Crossref
Gang-Jun Du, Zhi-Hui Song, Hai-Hong Lin, Xiao-feng Han, Shuo Zhang & Yi-ming Yang. (2008) Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells. Biochemical and Biophysical Research Communications 372:3, pages 497-502.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.